International Operations
NATCO exports both API’s and Finished Dosage Forms that comply with International standards to various markets across the globe. Today exports constitute about 50% of our total revenue. All the products are manufactured in facilities that are approved by various health regulatory agencies like US FDA, German Health Authority Hamburg, Cofepris Mexico, Iran Health Authority, Korean FDA, Ministry of Health Greece, Infarmed Portugal, etc
Currently products are exported to:
- North America
- Europe
- South America
- Middle East
- South East Asia
Recent developments:
- NATCO and Levomed LLC, USA, in 2011, formed a Joint Venture Company named, NATCOFARMA DO BRASIL, to distribute and sell pharmaceutical products in Brazil.
-
- NATCO and Renata, Bangladesh signed a MOU to set up a company – Renata Oncology Limited to develop and market anti cancer products in Bangladesh at affordable prices.
NATCO is open to form partnerships with committed players across the globe to work on collaborative projects.